{"id":9902,"date":"2022-10-27T22:04:50","date_gmt":"2022-10-28T02:04:50","guid":{"rendered":"https:\/\/aafa.org\/?page_id=9902"},"modified":"2025-09-04T12:50:49","modified_gmt":"2025-09-04T16:50:49","slug":"patient-focused-drug-development","status":"publish","type":"page","link":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development\/","title":{"rendered":"Patient Focused Drug Development"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”Research T-Hero Section” module_class=”hero tert” _builder_version=”4.18.0″ _module_preset=”default” background_image=”https:\/\/aafa.org\/wp-content\/uploads\/2022\/07\/AAFA-Website_Tertiary_Research.jpg” background_position=”top_right” custom_padding=”1%||1%||true|false” global_module=”1710″ saved_tabs=”all” locked=”off” collapsed=”on” global_colors_info=”{}”][et_pb_row _builder_version=”4.17.4″ _module_preset=”default” background_enable_image=”off” background_size=”initial” background_position=”bottom_left” background_horizontal_offset=”0%” custom_margin=”||||false|false” custom_padding=”2%||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Nav Parent Title” module_class=”tert-parent” _builder_version=”4.25.0″ _module_preset=”default” header_2_font=”|600|||||||” header_2_text_align=”left” header_2_text_color=”#FFFFFF” header_2_font_size=”32px” custom_margin=”||0px||false|false” global_colors_info=”{}”]<\/p>\n

Research and Reports<\/h2>\n

[\/et_pb_text][et_pb_code admin_label=”Breadcrumbs” module_class=”bcrumb” _builder_version=”4.17.4″ _module_preset=”default” text_orientation=”left” custom_margin=”||||false|false” custom_padding=”||||false|false” custom_css_main_element=”font-size:16px;||color: #fff;” global_colors_info=”{}”][\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Main Content” _builder_version=”4.17.4″ _module_preset=”default” custom_padding=”2%||2%||true|false” global_colors_info=”{}”][et_pb_row column_structure=”2_3,1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”2_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=” Intro Content” module_class=”secondary-intro” _builder_version=”4.18.0″ _module_preset=”default” text_text_color=”#505050″ text_font_size=”24px” text_line_height=”1.5em” header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” custom_margin=”||3%||false|false” global_colors_info=”{}”]<\/p>\n

Patient-Focused Drug Development<\/h2>\n

Patient-focused drug development (PFDD) intiatives seek to understand the needs of people living with various diseases including atopic dermatitis, asthma, and food allergies.<\/p>\n

[\/et_pb_text][et_pb_text admin_label=”Page Content” module_class=”secondary-intro” _builder_version=”4.19.0″ _module_preset=”default” text_text_color=”#505050″ text_line_height=”1.5em” header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” custom_margin=”||3%||false|false” global_colors_info=”{}”]<\/p>\n

AAFA has collaborated with several nonprofit organizations to create a series of opportunities for your perspective to inform and shape development of drugs and medical devices designed to treat atopic dermatitis (eczema)<\/a>, asthma<\/a>, and food allergy.<\/a><\/p>\n

Together, we co-hosted three patient-focused drug development (PFDD) meetings in the Washington, D.C. area. These meetings provided our community opportunities to speak directly to Food and Drug Administration (FDA) staff, representatives of pharmaceutical and medical device companies, and other key stakeholders.<\/p>\n

The testimonies and surveys from each of these meetings informed the publication of Voice of the Patient reports.<\/p>\n

Your voice and perspectives are essential for us to demonstrate the impact of these conditions on individuals and families. It helps drive research to focus on patient and family needs.<\/p>\n\n\n\n
\"Little<\/a>

Little Airways Big Voices: Voice of the Patient Report for Childhood Asthma<\/strong><\/a><\/p><\/div><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

[\/et_pb_text][et_pb_text admin_label=”Download PDFs” _builder_version=”4.18.0″ _module_preset=”default” text_text_color=”#505050″ link_font=”||||on||||” link_text_color=”#008c99″ header_4_font=”|600|||||||” header_4_text_color=”#008c99″ background_image=”https:\/\/aafa.org\/wp-content\/uploads\/2022\/06\/small_swoosh_BG.png” background_size=”initial” background_position=”top_left” background_horizontal_offset=”0%” background_vertical_offset=”0%” global_colors_info=”{}”]<\/p>\n

Download PDFs<\/h4>\n

More Than Skin Deep (Eczema)<\/a>\"Download<\/p>\n

Little Airways, Big Voices (Asthma) \"Download<\/a><\/p>\n

Food Allergy Collaborative (Food Allergy) \"Download<\/a><\/p>\n

[\/et_pb_text][et_pb_code admin_label=”Print” module_id=”print” module_class=”clearfix” _builder_version=”4.17.6″ _module_preset=”default” global_module=”5156″ saved_tabs=”all” global_colors_info=”{}”]<\/svg> Print post<\/a> [\/et_pb_code][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.17.4″ _module_preset=”default” custom_padding=”6%||||false|false” global_colors_info=”{}”][et_pb_text admin_label=”Racial Justice Blurb” module_class=”sidebar-blurb” _builder_version=”4.17.4″ _module_preset=”default” text_text_color=”#505050″ text_font_size=”16px” link_font=”|600||on|||||” link_text_align=”left” link_text_color=”#692d87″ link_font_size=”16px” header_4_font=”|600|||||||” header_4_text_align=”left” header_4_text_color=”#008c99″ header_4_font_size=”20px” background_image=”https:\/\/aafa.org\/wp-content\/uploads\/2022\/06\/teal_scribble.png” background_size=”initial” background_position=”top_left” custom_margin=”8%||8%||true|false” custom_padding=”2%||2%||true|false” global_module=”4735″ saved_tabs=”all” global_colors_info=”{}”]<\/p>\n

AAFA’s Commitment to Racial Justice<\/h4>\n

Over the past 15 years, there have been moderate advances in U.S. public policy, health care and research, but racial gaps in asthma outcomes have not changed. Minority groups continue to bear disproportionate hardship in managing asthma.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Blog Feed Section” module_class=”int-blog-ftr” _builder_version=”4.18.0″ _module_preset=”default” background_color=”#F5EDDF” custom_margin=”||||false|false” custom_padding=”2%||2%||false|false” top_divider_color=”#28BDBA” top_divider_flip=”horizontal” bottom_divider_color=”#28BDBA” bottom_divider_height=”50px” bottom_divider_arrangement=”above_content” global_module=”9338″ saved_tabs=”all” locked=”off” collapsed=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.18.0″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Related Content” _builder_version=”4.18.0″ _module_preset=”default” text_text_color=”#505050″ link_font=”||||on|||#008c99|” link_text_color=”#008c99″ header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” header_3_font=”|600|||||||” header_3_text_align=”left” header_3_text_color=”#008c99″ header_3_font_size=”28px” global_colors_info=”{}”]<\/p>\n

Related Content<\/h3>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.18.0″ _module_preset=”default” custom_margin=”0px||||false|false” custom_padding=”0px||0px||true|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”View More Link” _builder_version=”4.18.0″ _module_preset=”default” text_text_color=”#008C99″ link_font=”|600||on|||||” link_text_align=”right” link_text_color=”#008C99″ link_font_size=”18px” text_orientation=”right” global_colors_info=”{}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#692D87″]<\/p>\n

View more blog articles ><\/a><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

Research and ReportsPatient-Focused Drug Development Patient-focused drug development (PFDD) intiatives seek to understand the needs of people living with various diseases including atopic dermatitis, asthma, and food allergies.AAFA has collaborated […]<\/p>\n","protected":false},"author":14,"featured_media":0,"parent":6195,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-9902","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nPatient Focused Drug Development Meetings for Allergic Diseases | AAFA.org<\/title>\n<meta name=\"description\" content=\"AAFA partnered with other patient groups to host a Patient Focused Drug Development meetings to help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, asthma, and food allergies. The resulting Voice of the Patient reports focus on what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Patient Focused Drug Development\" \/>\n<meta property=\"og:description\" content=\"AAFA partnered with other patient groups to host a Patient Focused Drug Development meetings to help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, asthma, and food allergies. The resulting Voice of the Patient reports focus on what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Asthma and Allergy Foundation of America\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-04T16:50:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aafa.org\/wp-content\/uploads\/2022\/08\/more-than-skin-deep-understanding-eczema.png\" \/>\n\t<meta property=\"og:image:width\" content=\"747\" \/>\n\t<meta property=\"og:image:height\" content=\"714\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Patient Focused Drug Development Meeting for Atopic Dermatitis | AAFA.org\" \/>\n<meta name=\"twitter:description\" content=\"AAFA has partnered with four other patient groups to host a Patient Focused Drug Development meeting on September 23rd in the Washington, D.C. area. The meeting will help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/patient-focused-drug-development\\\/\",\"url\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/patient-focused-drug-development\\\/\",\"name\":\"Patient Focused Drug Development Meetings for Allergic Diseases | AAFA.org\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/patient-focused-drug-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/patient-focused-drug-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/aafa.org\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/more-than-skin-deep-understanding-eczema-300x287.png\",\"datePublished\":\"2022-10-28T02:04:50+00:00\",\"dateModified\":\"2025-09-04T16:50:49+00:00\",\"description\":\"AAFA partnered with other patient groups to host a Patient Focused Drug Development meetings to help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, asthma, and food allergies. The resulting Voice of the Patient reports focus on what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/patient-focused-drug-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/patient-focused-drug-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/patient-focused-drug-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/aafa.org\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/more-than-skin-deep-understanding-eczema.png\",\"contentUrl\":\"https:\\\/\\\/aafa.org\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/more-than-skin-deep-understanding-eczema.png\",\"width\":747,\"height\":714,\"caption\":\"More Than Skin Deep: Understanding the Lived Experience of Eczema\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/patient-focused-drug-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Research and Reports\",\"item\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our Research\",\"item\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Patient Focused Drug Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/aafa.org\\\/#website\",\"url\":\"https:\\\/\\\/aafa.org\\\/\",\"name\":\"Asthma and Allergy Foundation of America\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/aafa.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Patient Focused Drug Development Meetings for Allergic Diseases | AAFA.org","description":"AAFA partnered with other patient groups to host a Patient Focused Drug Development meetings to help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, asthma, and food allergies. The resulting Voice of the Patient reports focus on what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development\/","og_locale":"en_US","og_type":"article","og_title":"Patient Focused Drug Development","og_description":"AAFA partnered with other patient groups to host a Patient Focused Drug Development meetings to help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, asthma, and food allergies. The resulting Voice of the Patient reports focus on what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!","og_url":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development\/","og_site_name":"Asthma and Allergy Foundation of America","article_modified_time":"2025-09-04T16:50:49+00:00","og_image":[{"width":747,"height":714,"url":"https:\/\/aafa.org\/wp-content\/uploads\/2022\/08\/more-than-skin-deep-understanding-eczema.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_title":"Patient Focused Drug Development Meeting for Atopic Dermatitis | AAFA.org","twitter_description":"AAFA has partnered with four other patient groups to host a Patient Focused Drug Development meeting on September 23rd in the Washington, D.C. area. The meeting will help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development\/","url":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development\/","name":"Patient Focused Drug Development Meetings for Allergic Diseases | AAFA.org","isPartOf":{"@id":"https:\/\/aafa.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development\/#primaryimage"},"image":{"@id":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/aafa.org\/wp-content\/uploads\/2022\/08\/more-than-skin-deep-understanding-eczema-300x287.png","datePublished":"2022-10-28T02:04:50+00:00","dateModified":"2025-09-04T16:50:49+00:00","description":"AAFA partnered with other patient groups to host a Patient Focused Drug Development meetings to help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, asthma, and food allergies. The resulting Voice of the Patient reports focus on what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!","breadcrumb":{"@id":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development\/#primaryimage","url":"https:\/\/aafa.org\/wp-content\/uploads\/2022\/08\/more-than-skin-deep-understanding-eczema.png","contentUrl":"https:\/\/aafa.org\/wp-content\/uploads\/2022\/08\/more-than-skin-deep-understanding-eczema.png","width":747,"height":714,"caption":"More Than Skin Deep: Understanding the Lived Experience of Eczema"},{"@type":"BreadcrumbList","@id":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Research and Reports","item":"https:\/\/aafa.org\/asthma-allergy-research\/"},{"@type":"ListItem","position":2,"name":"Our Research","item":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/"},{"@type":"ListItem","position":3,"name":"Patient Focused Drug Development"}]},{"@type":"WebSite","@id":"https:\/\/aafa.org\/#website","url":"https:\/\/aafa.org\/","name":"Asthma and Allergy Foundation of America","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aafa.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/pages\/9902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/comments?post=9902"}],"version-history":[{"count":1,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/pages\/9902\/revisions"}],"predecessor-version":[{"id":27577,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/pages\/9902\/revisions\/27577"}],"up":[{"embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/pages\/6195"}],"wp:attachment":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/media?parent=9902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}